CB1 receptor–G protein association

No abstract is available for this paper.

• Publication year

  2001

• Venue

  FEBS Journal

• Publication date

  2001-02-01

• Fields of study

  Biology, Chemistry

• Identifiers
  DOI 10.1046/J.1432-1327.2001.01810.X
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The CB(1) cannabinoid receptor juxtamembrane C-terminal peptide confers activation to specific G proteins in brain.

  2000cited by this paper
• Inverse agonist properties of N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2, 4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide HCl (SR141716A) and 1-(2-chlorophenyl)-4-cyano-5-(4-methoxyphenyl)-1H-pyrazole-3-carboxyl ic acid phenylamide (CP-272871) for the CB(1) cannabinoid receptor.

  2000cited by this paper
• Pharmacology of cannabinoid receptor ligands.

  1999cited by this paper
• Regulation of Gi by the CB1 cannabinoid receptor C-terminal juxtamembrane region: structural requirements determined by peptide analysis.

  1999cited by this paper
• Cannabimimetic fatty acid derivatives: the anandamide family and other endocannabinoids.

  1999cited by this paper
• Signal transduction of eicosanoid CB1 receptor ligands.

  1999cited by this paper
• CB1 cannabinoid receptor: cellular regulation and distribution in N18TG2 neuroblastoma cells.

  1998cited by this paper
• Rethinking receptor-G protein-effector interactions.

  1998cited by this paper
• The Many Faces of G Protein Signaling*

  1998cited by this paper
• Molecular basis of receptor/G-protein-coupling selectivity.

  1998cited by this paper
• Characterization of CB1 cannabinoid receptors using receptor peptide fragments and site-directed antibodies.

  1998cited by this paper
• A Selective Inverse Agonist for Central Cannabinoid Receptor Inhibits Mitogen-activated Protein Kinase Activation Stimulated by Insulin or Insulin-like Growth Factor 1

  1997cited by this paper
• Identification of G‐protein binding sites of the human interleukin‐8 receptors by functional mapping of the intracellular loops

  1996cited by this paper
• Identification of the critical domains of the delta-opioid receptor involved in G protein coupling using site-specific synthetic peptides.

  1996cited by this paper
• Diversity and selectivity of receptor-G protein interaction.

  1996cited by this paper
• Mapping of G protein coupling sites of the angiotensin II type 1 receptor.

  1995cited by this paper
• Pharmacology of cannabinoid receptors.

  1995cited by this paper
• Inhibition of G protein-coupled receptor signaling by expression of cytoplasmic domains of the receptor.

  1994cited by this paper
• Chimeric muscarinic cholinergic:beta-adrenergic receptors that are functionally promiscuous among G proteins.

  1994cited by this paper
• Effect of forskolin and isobutylmethylxanthine on delta-opioid receptor activity in neuroblastoma x glioma NG108-15 cells.

  1993cited by this paper
• Solubilization of the cannabinoid receptor from rat brain and its functional interaction with guanine nucleotide-binding proteins.

  1993cited by this paper
• Antagonism of catecholamine receptor signaling by expression of cytoplasmic domains of the receptors.

  1993cited by this paper
• Cell-specific physical and functional coupling of human 5-HT1A receptors to inhibitory G protein alpha-subunits and lack of coupling to Gs alpha.

  1993cited by this paper
• Specificity of receptor-G protein interactions: searching for the structure behind the signal.

  1993cited by this paper
• Detection of G protein-activator regions in M4 subtype muscarinic, cholinergic, and alpha 2-adrenergic receptors based upon characteristics in primary structure.

  1992cited by this paper
• Multisite contacts involved in coupling of the β-adrenergic receptor with the stimulatory guanine-nucleotide-binding regulatory protein

  1991cited by this paper
• Diversity of G proteins in signal transduction

  1991cited by this paper
• A1 adenosine receptors of bovine brain couple to guanine nucleotide-binding proteins Gi1, Gi2, and Go.

  1991cited by this paper
• Identification of the pertussis toxin-sensitive G proteins in platelets, megakaryocytes, and human erythroleukemia cells.

  1990cited by this paper
• Specificity of receptor-G protein interactions. Discrimination of Gi subtypes by the D2 dopamine receptor in a reconstituted system.

  1990cited by this paper
• Differential regulation of amounts of the guanine-nucleotide-binding proteins Gi and Go in neuroblastoma x glioma hybrid cells in response to dibutyryl cyclic AMP.

  1988cited by this paper
• Cannabinoid inhibition of adenylate cyclase. Biochemistry of the response in neuroblastoma cell membranes.

  1985cited by this paper

• Neurensin-2 is a negative regulator of CB1 receptor.

  2025cites this paper
• Ultra-Sensitive Biosensor Based on Cell-Derived Nanovesicles for CB1 Receptor-Targeted Drug Development in a Live Cell-Free Platform.

  2025cites this paper
• Actomyosin-mediated inhibition of synaptic vesicle release under CB1R activation

  2024cites this paper
• A Cross Talk between the Endocannabinoid System and Different Systems Involved in the Pathogenesis of Hypertensive Retinopathy

  2023cites this paper
• Cannabinoid receptor interacting protein 1a interacts with myristoylated Gαi N terminus via a unique gapped β-barrel structure

  2021cites this paper
• Fit-for-purpose based testing and validation of antibodies to amino- and carboxy-terminal domains of cannabinoid receptor 1

  2021cites this paper
• The role of endocannabinoids in consolidation, retrieval, reconsolidation, and extinction of fear memory

  2021cites this paper
• The endocannabinoid system as a target for the treatment of neurological disorders

  2021cites this paper
• Subsynaptic Distribution, Lipid Raft Targeting and G Protein-Dependent Signalling of the Type 1 Cannabinoid Receptor in Synaptosomes from the Mouse Hippocampus and Frontal Cortex

  2021cites this paper
• Cannabinoid receptor CB1 and CB2 interacting proteins: Techniques, progress and perspectives.

  2021cites this paper
• Molecular Mechanism and Cannabinoid Pharmacology.

  2020cites this paper
• In vitro and in vivo pharmacological evaluation of the synthetic cannabinoid receptor agonist EG-018.

  2020cites this paper
• Activation of CB1R Promotes Lipopolysaccharide-Induced IL-10 Secretion by Monocytic Myeloid-Derived Suppressive Cells and Reduces Acute Inflammation and Organ Injury

  2020cites this paper
• Cannabinoid receptor subtype influence on neuritogenesis in human SH-SY5Y cells.

  2020cites this paper
• Structural Insights into CB1 Receptor Biased Signaling

  2019cites this paper
• Cannabinoids Exacerbate Alcohol Teratogenesis by a CB1-Hedgehog Interaction

  2019cites this paper
• Cannabinoid Receptor Interacting Protein 1a (CRIP1a): Function and Structure

  2019cites this paper
• Lipid regulation of placental mycotoxin transport

  2018cites this paper
• CB1 cannabinoid receptor‐phosphorylated fourth intracellular loop structure‐function relationships

  2018cites this paper
• Cannabinoid Receptor Interacting Protein 1a Competition with β-Arrestin for CB1 Receptor Binding Sites

  2017influential citation
• Bidirectional allosteric interactions between cannabinoid receptor 1 (CB1) and dopamine receptor 2 long (D2L) heterotetramers

  2017cites this paper
• Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease

  2017cites this paper
• Involvement of CB1 and TRPV1 receptors located in the ventral medial prefrontal cortex in the modulation of stress coping behavior.

  2017cites this paper
• CB1 cannabinoid receptor-mediated increases in cyclic AMP accumulation are correlated with reduced Gi/o function

  2016cites this paper
• Cannabinoid receptor interacting protein (CRIP1a) attenuates CB1R signaling in neuronal cells.

  2015cites this paper
• Mutations in the 'DRY' motif of the CB1 cannabinoid receptor result in biased receptor variants.

  2015cites this paper
• Cannabinoid Receptor–Interacting Protein 1a Modulates CB1 Receptor Signaling and Regulation

  2015cites this paper
• The Endocannabinoid System and Its Role in Regulating the Intrinsic Neural Circuitry of the Gastrointestinal Tract.

  2015cites this paper
• Cannabinoid receptor intracellular signalling: The long journey from binding sites to biological effects

  2014cites this paper
• Parsing the players: 2‐arachidonoylglycerol synthesis and degradation in the CNS

  2014cites this paper
• CB1 Receptor Allosteric Modulators Display Both Agonist and Signaling Pathway Specificity

  2013cites this paper
• DC T Cell Stimulatory Capacity Potassium Channel Function and Modulate Cannabinoids Affect Dendritic Cell (DC)

  2013cites this paper
• High fat diet and body weight have different effects on cannabinoid CB(1) receptor expression in rat nodose ganglia.

  2013cites this paper
• Effects of palmitoylation of Cys415 in helix 8 of the CB1 cannabinoid receptor on membrane localization and signalling

  2012cites this paper
• Peptides Derived from the Third Cytoplasmic Loop of the Serotonin Subtype 1B Receptor Selectively Inhibit Transmission of Serotoninergic Signals via Their Homologous Receptors

  2012cites this paper
• Signal Protein-Derived Peptides as Functional Probes and Regulators of Intracellular Signaling

  2011cites this paper
• Biaryl ether and biaryl analogs as cannabinoid receptor ligands

  2011cites this paper
• The cannabinoid type‐1 receptor carboxyl‐terminus, more than just a tail

  2011influential citation
• Development of non-hormonal regulators of the adenylyl cyclase signaling system based on the peptides, derivatives of the third intracellular loop of somatostatin receptors

  2011cites this paper
• Functionally selective cannabinoid receptor signalling: therapeutic implications and opportunities.

  2010cites this paper
• Cannabinoid Receptor 1 trafficking and the role of the intracellular pool: implications for therapeutics.

  2010cites this paper
• CB(1) cannabinoid receptors and their associated proteins.

  2010cites this paper
• Hydrophobic residues in helix 8 of cannabinoid receptor 1 are critical for structural and functional properties.

  2010cites this paper
• Interaction of endocannabinoid receptors with biological membranes.

  2010cites this paper
• The Peptides Mimicking the Third Intracellular Loop of 5-Hydroxytryptamine Receptors of the Types 1B and 6 Selectively Activate G Proteins and Receptor-Specifically Inhibit Serotonin Signaling via the Adenylyl Cyclase System

  2010cites this paper
• Effects of cannabinoid receptor interacting protein (CRIP1a) on cannabinoid (CB1) receptor function

  2009cites this paper
• Cannabinoid Receptor Signal Transduction Pathways

  2009cites this paper
• Cannabinoid Agonist and Inverse Agonist Regulation of G Protein Coupling

  2009cites this paper
• Functional Selectivity at Receptors for Cannabinoids and Other Lipids

  2009cites this paper
• Agonist-Selective Coupling of G Protein-Coupled Receptors

  2009cites this paper
• Polycationic peptides as nonhormonal regulators of chemosignal systems

  2009cites this paper
• Specific detection of CB1 receptors; cannabinoid CB1 receptor antibodies are not all created equal!

  2008cites this paper
• Cannabinoids Affect Dendritic Cell (DC) Potassium Channel Function and Modulate DC T Cell Stimulatory Capacity1

  2008cites this paper
• Modelling of the concentration—effect relationship of THC on central nervous system parameters and heart rate — insight into its mechanisms of action and a tool for clinical research and development of cannabinoids

  2008cites this paper
• Helix 8 Leu in the CB1 Cannabinoid Receptor Contributes to Selective Signal Transduction Mechanisms*

  2007cites this paper
• Differential modulation of type 1 and type 2 cannabinoid receptors along the neuroimmune axis.

  2007cites this paper
• CB1 Cannabinoid Receptor Activity Is Modulated by the Cannabinoid Receptor Interacting Protein CRIP 1a

  2007cites this paper
• The Pharmacology of the Cannabinoid System—A Question of Efficacy and Selectivity

  2007cites this paper
• Adenosine A2a blockade prevents synergy between μ-opiate and cannabinoid CB1 receptors and eliminates heroin-seeking behavior in addicted rats

  2006cites this paper
• Activator of G protein signaling 3 regulates opiate activation of protein kinase A signaling and relapse of heroin-seeking behavior.

  2005cites this paper
• NMR Structural Comparison of the Cytoplasmic Juxtamembrane Domains of G-protein-coupled CB1 and CB2 Receptors in Membrane Mimetic Dodecylphosphocholine Micelles*

  2005cites this paper
• The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications.

  2005cites this paper
• Cannabinoid receptor signaling.

  2005cites this paper
• Lipids, lipid rafts and caveolae: their importance for GPCR signaling and their centrality to the endocannabinoid system.

  2005cites this paper
• Use of Peptide Strategy for Study of Molecular Mechanisms of Hormonal Signal Transduction into Cell

  2005cites this paper
• Chemically Distinct Ligands Promote Differential CB1 Cannabinoid Receptor-Gi Protein Interactions

  2005cites this paper
• Cannabinoid targets for pain therapeutics

  2005cites this paper
• Cannabinoid receptor‐mediated regulation of intracellular calcium by Δ9‐tetrahydrocannabinol in resting T cells

  2004cites this paper
• A Cyclic Peptide Mimicking the Third Intracellular Loop of the V2 Vasopressin Receptor Inhibits Signaling through Its Interaction with Receptor Dimer and G Protein*

  2004cites this paper
• The cannabinoid receptor antagonist SR-141716 does not readily antagonize open-field effects induced by the cannabinoid receptor agonist (R)-methanandamide in rats.

  2003cites this paper
• The β2-adrenergic receptor specifically sequesters gs but signals through both Gs and Gi/o in rat sympathetic neurons

  2003cites this paper
• (R)-Methanandamide and delta9-tetrahydrocannabinol-induced operant rate decreases in rats are not readily antagonized by SR-141716A.

  2003cites this paper
• Expression of functionally active cannabinoid receptor CB1 in the human prostate gland

  2003cites this paper
• The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis

  2003cites this paper
• G protein specificity: traffic direction required.

  2002cites this paper
• Modulation of cannabinoid agonist binding by 5‐HT in the rat cerebellum

  2002cites this paper
• Cannabinoid receptor‐G protein interactions: Gαi1‐bound structures of IC3 and a mutant with altered G protein specificity

  2002cites this paper
• Endocannabinoids and their actions.

  2002cites this paper
• CB(1) cannabinoid receptor-G protein association: a possible mechanism for differential signaling.

  2002cites this paper
• Despite substantial degradation, 2‐arachidonoylglycerol is a potent full efficacy agonist mediating CB1 receptor‐dependent G‐protein activation in rat cerebellar membranes

  2001cites this paper
• Signal transduction interactions between CB1 cannabinoid and dopamine receptors in the rat and monkey striatum.

  2001cites this paper